Taiko Pharmaceutical (4574.T) Earnings Analysis

Taiko Pharmaceutical (4574.T) next reports earnings on 2026-08-13. Trailing P/E 24.48.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4574.T next report earnings?

Next earnings date2026-08-13
Consensus EPS estimaten/a
Revenue estimate1.29B

4574.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-1.89 JPYn/an/an/a
2026-02-135.05 JPYn/an/an/a
2025-08-08-0.26 JPYn/an/an/a
2025-05-095.82 JPYn/an/an/a
2025-02-133.67 JPYn/an/an/a
2024-11-08-1 JPYn/an/an/a
2024-08-095.82 JPYn/an/an/a

4574.T valuation and analyst view

Trailing P/E24.48
Trailing EPS10.666 JPY
Price / book1.59
Dividend yield1.26%
Market cap13.67B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Taiko Pharmaceutical (4574.T)'s next earnings date?

Taiko Pharmaceutical is next scheduled to report on 2026-08-13 and revenue estimate of 1.29B.

Did 4574.T beat earnings last quarter?

Consensus estimate data was not available for 4574.T's 2026-05-14 report.

What is 4574.T's current P/E ratio and EPS?

4574.T trades at a trailing P/E of 24.48 on trailing EPS of 10.666414705785956 JPY.

What do analysts rate 4574.T?

4574.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.